Tefron Statistics
Total Valuation
Tefron has a market cap or net worth of 94.26 million. The enterprise value is 105.20 million.
| Market Cap | 94.26M |
| Enterprise Value | 105.20M |
Important Dates
The next estimated earnings date is Friday, March 14, 2025.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | Mar 26, 2024 |
Share Statistics
Tefron has 12.57 million shares outstanding. The number of shares has increased by 4.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 12.57M |
| Shares Change (YoY) | +4.99% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.35% |
| Owned by Institutions (%) | 9.33% |
| Float | 3.78M |
Valuation Ratios
The trailing PE ratio is 6.30.
| PE Ratio | 6.30 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.21, with an EV/FCF ratio of 4.69.
| EV / Earnings | 6.60 |
| EV / Sales | 0.36 |
| EV / EBITDA | 3.21 |
| EV / EBIT | 4.15 |
| EV / FCF | 4.69 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.70 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 0.52 |
| Debt / FCF | 0.76 |
| Interest Coverage | 12.04 |
Financial Efficiency
Return on equity (ROE) is 23.54% and return on invested capital (ROIC) is 17.46%.
| Return on Equity (ROE) | 23.54% |
| Return on Assets (ROA) | 10.83% |
| Return on Capital (ROIC) | 17.46% |
| Revenue Per Employee | 246,841 |
| Profits Per Employee | 13,462 |
| Employee Count | 1,184 |
| Asset Turnover | 2.00 |
| Inventory Turnover | 4.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +100.00% in the last 52 weeks. The beta is 1.10, so Tefron's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +100.00% |
| 50-Day Moving Average | 7.48 |
| 200-Day Moving Average | 6.56 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | 15 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 137.58 |
Income Statement
In the last 12 months, Tefron had revenue of 292.26 million and earned 15.94 million in profits. Earnings per share was 1.19.
| Revenue | 292.26M |
| Gross Profit | 67.12M |
| Operating Income | 25.38M |
| Pretax Income | 20.75M |
| Net Income | 15.94M |
| EBITDA | 32.78M |
| EBIT | 25.38M |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 6.08 million in cash and 17.03 million in debt, giving a net cash position of -10.95 million or -0.87 per share.
| Cash & Cash Equivalents | 6.08M |
| Total Debt | 17.03M |
| Net Cash | -10.95M |
| Net Cash Per Share | -0.87 |
| Equity (Book Value) | 75.11M |
| Book Value Per Share | 6.02 |
| Working Capital | 45.45M |
Cash Flow
In the last 12 months, operating cash flow was 29.46 million and capital expenditures -7.05 million, giving a free cash flow of 22.42 million.
| Operating Cash Flow | 29.46M |
| Capital Expenditures | -7.05M |
| Free Cash Flow | 22.42M |
| FCF Per Share | 1.78 |
Margins
Gross margin is 22.96%, with operating and profit margins of 8.68% and 5.45%.
| Gross Margin | 22.96% |
| Operating Margin | 8.68% |
| Pretax Margin | 7.10% |
| Profit Margin | 5.45% |
| EBITDA Margin | 11.22% |
| EBIT Margin | 8.68% |
| FCF Margin | 7.67% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 2.13%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 2.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 12.52% |
| Buyback Yield | -4.99% |
| Shareholder Yield | -2.85% |
| Earnings Yield | 15.88% |
| FCF Yield | 23.78% |
Stock Splits
The last stock split was on January 22, 2009. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 22, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Tefron has an Altman Z-Score of 2.99. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.99 |
| Piotroski F-Score | n/a |